Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Neurology|December 26, 2014
Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriersRick C Helmich, Avner Thaler, Bart F L van Nuenen, et al.
BMC Neurology|April 18, 2023
The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocolNoa Bregman, Tamara Shiner, Gitit Kavé, et al.
NPJ Parkinson'S Disease|October 21, 2022
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's diseaseDafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, et al.
Frontiers in Neurology|June 6, 2019
Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's DiseaseTal Kozlovski, Alexis Mitelpunkt, Avner Thaler, et al.
Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|January 30, 2013
Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersAvner Thaler, Anat Mirelman, Rick C Helmich, et al.
Molecular Genetics and Metabolism|October 31, 2019
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Orly Goldstein, Mali Gana-Weisz, Danielle Cohen-Avinoam, et al.
NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.
Journal of Parkinson'S Disease|May 17, 2021
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory MarkersAvner Thaler, Nurit Omer, Nir Giladi, et al.
The European Journal of Neuroscience|November 5, 2015
Intact working memory in non-manifesting LRRK2 carriers--an fMRI studyAvner Thaler, Rick C Helmich, Ayelet Or-Borichev, et al.
Pageof 9